Breakthrough? stool test may spot Alzheimer's before symptoms worsen
NCT ID NCT06481878
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is testing a new, non-invasive way to detect Alzheimer's disease by looking for specific proteins (amyloid and tau) in stool samples. The goal is to see if these proteins can serve as early warning signs, potentially allowing for earlier diagnosis and treatment. Researchers will compare stool samples from 115 people with and without Alzheimer's to validate this approach.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 115 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Oct 2024
- Expected to finish
-
Oct 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Single-center study, recruitment among patients consulting the CMRR of the Alpine arc
- Ages
-
40 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: For subjects with Alzheimer's disease MA TCM (A+ T+): * Subjects diagnosed with AD according to IWG 2021 criteria * Subject at the stage of major cognitive impairment * At least 40 years of age * Presence of a caregiver or support person * No informed opposition For subjects with AD TCm (A+ T+): * Subject diagnosed with AD according to IWG 2021 criteria * Subject at the stage of minor cognitive impairment * Minimum age 40 * No informed opposition For subjects with minor or major cognitive impairment who do not have AD TC Non-AD LCR negative (A- T-) * Subject at stage of minor or major cognitive impairment * CSF negative (A-T-) for Alzheimer's disease biomarkers: A-T- according to ATN classification * Minimum age 40 * No informed objection and TCm CSFdiscordant (A+ T-) or (A- T+): * Subject at stage of minor cognitive impairment * CSF discordant (A-T+ or A+T-) with Alzheimer's disease biomarkers * Minimum age 40 * No informed opposition For healthy volunteers (VS) : * No cognitive complaints * MMSE ≥ 26 * CDR 0 * Minimum age 40 * No informed opposition Exclusion Criteria: For MA TCM (A+ T+), MA TCm (A+T+) and TC Non MA LCR negatif (A-T-) and TCm LCRdiscordant (A+ T-) or (A- T+): * Inability to understand search instructions or to give informed non-opposition * Absence of social security affiliation or plan * Persons covered by articles L1121-5 to L1121-8 of the CSP (legally protected adult, subject under administrative or judicial supervision) For healthy volunteers: * Incapacity to understand research instructions or to give informed non-opposition * Persons covered by articles L1121-5 to L1121-8 of the CSP (legally protected adult, subject under administrative or judicial supervision) * Absence of social security affiliation or of such a scheme
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Alzheimer disease are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Grenoble Alpes University Hospital
RECRUITINGGrenoble, 38043, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a massive data registry crack the code of Parkinson's and related brain diseases?
- Can a gentle electric current calm the mind in Alzheimer's?
- Alzheimer's vaccine aims to clear amyloid before memory fades
- Blood, eye, and brain scans team up to spot Alzheimer's earlier
- Can a home device slow Alzheimer's? pilot study tests pulsed electromagnetic therapy
- Eye scans as a window to the body: study probes retinal imaging across diseases